LIETUVOS IMUNOLOGŲ DRAUGIJA - financials and debts

Company age: 30 y. 5 mo.

Update

Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - - - - 1,662 2,988 8,287 60,262
Profit before tax - - - - 0 0 0 15,411
Net profit - - - - 0 0 0 15,411
Equity 0 0 0 0 0 0 0 0
Liabilities 0 0 0 1,396 0 0 300 300
Non-current assets 0 0 0 0 0 0 0 0
Current assets 14,796 9,872 5,890 2,339 3,632 24,103 31,650 46,961
Total assets 14,796 9,872 5,890 2,339 3,632 24,103 31,650 46,961
Financial indicators
Revenue change y/y - - - - - +79.8% +177.3% +627.2%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. - - - - 0.0% 0.0% 0.0% 32.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - - - - -
Profit margin Net profit margin. Shows the overall profitability of the company. - - - - 0.0% 0.0% 0.0% 25.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - 0.0% 0.0% 0.0% 25.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - - - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Social security debts

The company had no debts to Sodra

VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
LIETUVOS IMUNOLOGU DRAUGIJA (code 190735292) is an Association engaged in activities of professional membership organisations. In 2025, it generated revenue of EUR 60.3K and net profit of EUR 15.4K, which corresponds to a profit margin of 25.6%. The company’s revenue trajectory over the last three years shows a marked increase: EUR 3.0K in 2023, EUR 8.3K in 2024, and EUR 60.3K in 2025. Profit was reported in 2025, while earlier years show only revenue figures, indicating that the latest year was the strongest period in the available series. Total assets also expanded steadily from EUR 24.1K in 2023 to EUR 31.6K in 2024 and EUR 47.0K in 2025. Liabilities were low at EUR 300 in both 2024 and 2025, leaving the balance sheet with a modest obligation level relative to assets. The reported return on assets was 32.8%, and asset turnover was 1.28x in 2025, suggesting effective use of the asset base.